Singapore markets closed
Straits Times Index
3,331.70 +5.42 (+0.16%) S&P 500
5,467.13 -2.17 (-0.04%) Dow
38,968.90 -143.26 (-0.37%) Nasdaq
17,778.73 +61.07 (+0.34%) Bitcoin USD
61,804.20 +230.02 (+0.37%) CMC Crypto 200
1,282.36 -1.43 (-0.11%)
Day One Biopharmaceuticals, Inc. (DAWN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:23AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.17B |
| Enterprise value | 853.38M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.95 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -4.30 |
Trading information
Stock price history
| Beta (5Y monthly) | -1.53 |
| 52-week change 3 | 6.43% |
| S&P500 52-week change 3 | 24.96% |
| 52-week high 3 | 18.07 |
| 52-week low 3 | 9.67 |
| 50-day moving average 3 | 14.68 |
| 200-day moving average 3 | 13.87 |
Share statistics
| Avg vol (3-month) 3 | 1.15M |
| Avg vol (10-day) 3 | 947.53k |
| Shares outstanding 5 | 87.39M |
| Implied shares outstanding 6 | 87.39M |
| Float 8 | 55.96M |
| % held by insiders 1 | 19.70% |
| % held by institutions 1 | 85.00% |
| Shares short (31 May 2024) 4 | 10.66M |
| Short ratio (31 May 2024) 4 | 11.95 |
| Short % of float (31 May 2024) 4 | 15.23% |
| Short % of shares outstanding (31 May 2024) 4 | 12.20% |
| Shares short (prior month 30 Apr 2024) 4 | 11.19M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -42.67% |
| Return on equity (ttm) | -69.97% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -221.92M |
| Net income avi to common (ttm) | -208.94M |
| Diluted EPS (ttm) | -2.50 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 317.94M |
| Total cash per share (mrq) | 3.64 |
| Total debt (mrq) | 300k |
| Total debt/equity (mrq) | 0.10% |
| Current ratio (mrq) | 10.93 |
| Book value per share (mrq) | 3.40 |
Cash flow statement
| Operating cash flow (ttm) | -170.6M |
| Levered free cash flow (ttm) | -95.76M |
© 2024 Yahoo. All rights reserved.